Harris & Harris Group (TINY) 3.38 $TINY
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc.
GlobeNewswire - Thu Apr 17, 8:14AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, released its blog post on Champions Oncology and why it is on the cutting edge of personalized medicine.
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co.
GlobeNewswire - Tue Apr 08, 11:52AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by portfolio company, Mersana Therapeutics, Inc., that it has entered into a collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) to develop next-generation Fleximer(R) antibody-drug conjugates (ADCs). Mersana's proprietary conjugation technology is comprised of the company's biodegradable Fleximer polymer and a broad array of customizable linker chemistries matched to Mersana's diverse, cytotoxic payloads.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc.
GlobeNewswire - Mon Apr 07, 10:11AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, released its blog post on Metabolon and why it is on the cutting edge of healthcare analytics and personalized medicine. This is the second in our series of detailed postings that will provide current and future investors an opportunity to take a deeper look into the potentially most impactful companies in our portfolio (http://www.hhvc.com/blog/blog-details?BlogPostID=f0aa3d92-d75d-4eff-94a3-d8d51116fd03). The first blog in this series focused on D-Wave Systems, Inc. (http://www.hhvc.com/blog/blog-details?BlogPostID=605642b6-a290-4be5-8200-6769192c1300).
Harris & Harris Group Launches Blog Series to Highlight Most Impactful Portfolio Companies
GlobeNewswire - Tue Mar 25, 7:45AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, has initiated a series of detailed blog postings that will provide current and future investors an opportunity to take a deeper look into the potentially most impactful companies in our portfolio.
Harris & Harris Group Reports Financial Statements as of December 31, 2013 and Posts Annual Letter to Shareholders on Website
GlobeNewswire - Mon Mar 17, 7:31AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), reported today that, as of December 31, 2013, its net asset value and net asset value per share were $122,701,575 and $3.93, respectively. The Company's Annual Report on Form 10-K may be accessed at http://ir.hhvc.com/sec.cfm.
Save the Date: Harris & Harris Group "Meet the Portfolio Day" Wednesday April 30, 8am-1pm, The Harvard Club
GlobeNewswire - Wed Mar 12, 7:55AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, will be hosting "Meet the Portfolio Day" on Wednesday, April 30, 2014, at the Harvard Club in New York City, from 8 a.m. to 1 p.m. The CEOs of seven of our portfolio companies working in critical areas such as supercomputing, diabetes, cancer and agriculture will be presenting. We are excited to present an update on our corporate strategy as well.
Harris & Harris Group Notes D-Wave's Article in Phys.Org
GlobeNewswire - Mon Mar 10, 9:03AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the article posted by Robert Perkins on Phys.Org on Harris & Harris Group's portfolio company, D-Wave Systems, Inc., on March 5, 2014. The article, titled "D-Wave chip passes rigorous tests," discusses the results of research published on February 28, 2014, in Nature Physics.
Harris & Harris Group Notes Metabolon's Collaboration Agreement With Human Longevity Inc. to Provide Metabolomic Profiling Services
GlobeNewswire - Fri Mar 07, 2:57AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by its portfolio company, Metabolon, Inc., that it has signed an agreement with newly-launched Human Longevity Inc. (HLI), whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to address diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database. In the initial term of the agreement, Metabolon will perform small molecule analysis of 10,000 subjects and collaborate with HLI to map changes in the small molecules to end points of disease and gene mutations.
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc.
GlobeNewswire - Tue Mar 04, 7:49AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, is pleased to announce the founding of ProMuc, Inc., and our initial investment of $350,001. ProMuc brings together the expertise of Prof. Katharina Ribbeck at MIT, a leading researcher on mucin biology, and the carbohydrate chemistry technology of Corden Pharma to focus on the development of synthetic mucins for lubrication and antimicrobial applications.
Harris & Harris Group Portfolio Company, HZO, Wins "Best of Show" at VCIR Winter Conference
GlobeNewswire - Mon Mar 03, 4:20PM CST
Harris & Harris Group Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, announces that its portfolio company, HZO, Inc., was voted "Best of Show" at the 31st Annual Venture Capital in the Rockies (VCIR) Winter conference. HZO was one of 20 presenting companies at VCIR Winter 2014, held in Beaver Creek, CO, on February 24-26, 2014.
Harris & Harris Group to Host Conference Call on Fourth-Quarter 2013 Financial Results on March 19, 2014
GlobeNewswire - Thu Feb 27, 9:10AM CST
The management of Harris & Harris Group, Inc., (Nasdaq:TINY), will hold a conference call to discuss the Company's financial results for its fourth quarter 2013, to update shareholders and analysts on our business and to answer questions, on Wednesday, March 19, 2014, at 10:00 a.m. Eastern Time.
Harris & Harris Group Announces the Consulting Engagement of Peter J. Boni as a Senior Advisor
GlobeNewswire - Wed Feb 26, 7:42AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, announces the engagement of Peter J. Boni as a Senior Advisor to the Company, reporting to the CEO and the Board of Directors. His responsibilities will include working with management on strategy, corporate communications and partnering.
Harris & Harris Group Announced as Top Ranked High-Tech Investor by SBIR Source and as an Investor in Innovation by Forbes.com
GlobeNewswire - Wed Feb 19, 12:21PM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, is pleased to announce that we have been ranked #1 by SBIR Source as the Top Investor in High-Technology. The article discusses in detail the Small Business Innovation Research ("SBIR"
funding program, which funds cutting edge technology and research with commercial applications. SBIR funding, according to GrantIQ, "is a very strong indicator that companies are high tech or hard tech." Harris & Harris Group topped the rankings based on the percentage of SBIR-backed companies in their historical portfolios and weighted according to the number of companies in each portfolio. The detailed rankings and methodologies used to derive them can be accessed at http://sbirsource.com/sbir/investors/.
Harris & Harris Group Notes Molecular Imprints' Semiconductor Business to be Acquired by Canon
GlobeNewswire - Fri Feb 14, 7:49AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by its portfolio company, Molecular Imprints, Inc. ("MII" , that it has signed an agreement to sell its semiconductor imprint lithography equipment business to Canon Inc. of Tokyo, Japan. Canon began conducting research into nanoimprint technology in 2004 to enter the market for lithography equipment for leading-edge high-resolution patterning. Since 2009, Canon has been carrying out joint development with MII and a major semiconductor manufacturer for mass production using MII's Jet and Flash Imprint Lithography (J-FIL) technology. The press release announcing the acquisition can be found at http://ca.finance.yahoo.com/news/molecular-im...00231.html.
10-Q: FAIRMOUNT BANCORP, INC.
Edgar Online - Thu Feb 13, 8:41AM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Harris & Harris Group Notes D-Wave's Article in Time Magazine
GlobeNewswire - Mon Feb 10, 7:47AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the article by Lev Grossman on Harris & Harris Group's portfolio company, D-Wave Systems, Inc., featured on the cover of the February 17, 2014, issue of Time Magazine. The article, titled "The Quantum Quest for a Revolutionary Computer," introduces readers to the differences between classical and quantum computing and discusses D-Wave's quantum computing technology. The article also discusses D-Wave's early customer traction and the outstanding questions around D-Wave's technology and differentiation. A summary of the article can be viewed at http://content.time.com/time/magazine/article...06,00.html and http://business.time.com/2014/02/06/9-ways-qu...verything/.
10-Q: BEAZER HOMES USA INC
Edgar Online - Fri Jan 31, 4:29PM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Executive Overview and Outlook
Harris & Harris Group Notes Mersana's Second Milestone Payment in Fleximer ADC Collaboration With Endo Pharmaceuticals
GlobeNewswire - Tue Jan 14, 1:44PM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by portfolio company, Mersana Therapeutics, Inc., that it has achieved the second preclinical milestone in its collaboration with Endo Pharmaceuticals. In 2012, Mersana and Endo entered into a multi-target, oncology-focused partnership to develop next-generation Fleximer antibody-drug conjugates (ADCs).
Harris & Harris Group Notes Metabolon's Closing on a $15 Million Series E Financing
GlobeNewswire - Mon Jan 06, 8:30AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the close of Metabolon's $15 million Series E financing. Metabolon is a metabolomics-based diagnostic tests and research services company based in Research Triangle Park, NC. Two new investors, Camden Partners and Sumitomo Corporation, joined existing investors in the Series E financing. Harris & Harris Group invested approximately $1.25 million, bringing its cumulative investment in Metabolon to $7.225 million.
Harris & Harris Group Notes ABSMaterials' Series B Financing
GlobeNewswire - Fri Nov 22, 8:00AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by ABSMaterials, Inc., of its Series B financing. RKS Ventures, a strategic investment group based in Nashua, NH, led the Series B financing round, raising over $4 million. RKS is joined by existing investors, including Harris & Harris Group and a number of individuals. The funding will be used for manufacturing improvements and expansion into new markets, including Asia.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc.
GlobeNewswire - Thu Apr 17, 8:14AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, released its blog post on Champions Oncology and why it is on the cutting edge of personalized medicine.
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co.
GlobeNewswire - Tue Apr 08, 11:52AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by portfolio company, Mersana Therapeutics, Inc., that it has entered into a collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) to develop next-generation Fleximer(R) antibody-drug conjugates (ADCs). Mersana's proprietary conjugation technology is comprised of the company's biodegradable Fleximer polymer and a broad array of customizable linker chemistries matched to Mersana's diverse, cytotoxic payloads.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc.
GlobeNewswire - Mon Apr 07, 10:11AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, released its blog post on Metabolon and why it is on the cutting edge of healthcare analytics and personalized medicine. This is the second in our series of detailed postings that will provide current and future investors an opportunity to take a deeper look into the potentially most impactful companies in our portfolio (http://www.hhvc.com/blog/blog-details?BlogPostID=f0aa3d92-d75d-4eff-94a3-d8d51116fd03). The first blog in this series focused on D-Wave Systems, Inc. (http://www.hhvc.com/blog/blog-details?BlogPostID=605642b6-a290-4be5-8200-6769192c1300).
Harris & Harris Group Launches Blog Series to Highlight Most Impactful Portfolio Companies
GlobeNewswire - Tue Mar 25, 7:45AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, has initiated a series of detailed blog postings that will provide current and future investors an opportunity to take a deeper look into the potentially most impactful companies in our portfolio.
Harris & Harris Group Reports Financial Statements as of December 31, 2013 and Posts Annual Letter to Shareholders on Website
GlobeNewswire - Mon Mar 17, 7:31AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), reported today that, as of December 31, 2013, its net asset value and net asset value per share were $122,701,575 and $3.93, respectively. The Company's Annual Report on Form 10-K may be accessed at http://ir.hhvc.com/sec.cfm.
Save the Date: Harris & Harris Group "Meet the Portfolio Day" Wednesday April 30, 8am-1pm, The Harvard Club
GlobeNewswire - Wed Mar 12, 7:55AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, will be hosting "Meet the Portfolio Day" on Wednesday, April 30, 2014, at the Harvard Club in New York City, from 8 a.m. to 1 p.m. The CEOs of seven of our portfolio companies working in critical areas such as supercomputing, diabetes, cancer and agriculture will be presenting. We are excited to present an update on our corporate strategy as well.
Harris & Harris Group Notes D-Wave's Article in Phys.Org
GlobeNewswire - Mon Mar 10, 9:03AM CDT
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the article posted by Robert Perkins on Phys.Org on Harris & Harris Group's portfolio company, D-Wave Systems, Inc., on March 5, 2014. The article, titled "D-Wave chip passes rigorous tests," discusses the results of research published on February 28, 2014, in Nature Physics.
Harris & Harris Group Notes Metabolon's Collaboration Agreement With Human Longevity Inc. to Provide Metabolomic Profiling Services
GlobeNewswire - Fri Mar 07, 2:57AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by its portfolio company, Metabolon, Inc., that it has signed an agreement with newly-launched Human Longevity Inc. (HLI), whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to address diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database. In the initial term of the agreement, Metabolon will perform small molecule analysis of 10,000 subjects and collaborate with HLI to map changes in the small molecules to end points of disease and gene mutations.
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc.
GlobeNewswire - Tue Mar 04, 7:49AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, is pleased to announce the founding of ProMuc, Inc., and our initial investment of $350,001. ProMuc brings together the expertise of Prof. Katharina Ribbeck at MIT, a leading researcher on mucin biology, and the carbohydrate chemistry technology of Corden Pharma to focus on the development of synthetic mucins for lubrication and antimicrobial applications.
Harris & Harris Group Portfolio Company, HZO, Wins "Best of Show" at VCIR Winter Conference
GlobeNewswire - Mon Mar 03, 4:20PM CST
Harris & Harris Group Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, announces that its portfolio company, HZO, Inc., was voted "Best of Show" at the 31st Annual Venture Capital in the Rockies (VCIR) Winter conference. HZO was one of 20 presenting companies at VCIR Winter 2014, held in Beaver Creek, CO, on February 24-26, 2014.
Harris & Harris Group to Host Conference Call on Fourth-Quarter 2013 Financial Results on March 19, 2014
GlobeNewswire - Thu Feb 27, 9:10AM CST
The management of Harris & Harris Group, Inc., (Nasdaq:TINY), will hold a conference call to discuss the Company's financial results for its fourth quarter 2013, to update shareholders and analysts on our business and to answer questions, on Wednesday, March 19, 2014, at 10:00 a.m. Eastern Time.
Harris & Harris Group Announces the Consulting Engagement of Peter J. Boni as a Senior Advisor
GlobeNewswire - Wed Feb 26, 7:42AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, announces the engagement of Peter J. Boni as a Senior Advisor to the Company, reporting to the CEO and the Board of Directors. His responsibilities will include working with management on strategy, corporate communications and partnering.
Harris & Harris Group Announced as Top Ranked High-Tech Investor by SBIR Source and as an Investor in Innovation by Forbes.com
GlobeNewswire - Wed Feb 19, 12:21PM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, is pleased to announce that we have been ranked #1 by SBIR Source as the Top Investor in High-Technology. The article discusses in detail the Small Business Innovation Research ("SBIR"
funding program, which funds cutting edge technology and research with commercial applications. SBIR funding, according to GrantIQ, "is a very strong indicator that companies are high tech or hard tech." Harris & Harris Group topped the rankings based on the percentage of SBIR-backed companies in their historical portfolios and weighted according to the number of companies in each portfolio. The detailed rankings and methodologies used to derive them can be accessed at http://sbirsource.com/sbir/investors/. Harris & Harris Group Notes Molecular Imprints' Semiconductor Business to be Acquired by Canon
GlobeNewswire - Fri Feb 14, 7:49AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by its portfolio company, Molecular Imprints, Inc. ("MII"
, that it has signed an agreement to sell its semiconductor imprint lithography equipment business to Canon Inc. of Tokyo, Japan. Canon began conducting research into nanoimprint technology in 2004 to enter the market for lithography equipment for leading-edge high-resolution patterning. Since 2009, Canon has been carrying out joint development with MII and a major semiconductor manufacturer for mass production using MII's Jet and Flash Imprint Lithography (J-FIL) technology. The press release announcing the acquisition can be found at http://ca.finance.yahoo.com/news/molecular-im...00231.html. 10-Q: FAIRMOUNT BANCORP, INC.
Edgar Online - Thu Feb 13, 8:41AM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Harris & Harris Group Notes D-Wave's Article in Time Magazine
GlobeNewswire - Mon Feb 10, 7:47AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the article by Lev Grossman on Harris & Harris Group's portfolio company, D-Wave Systems, Inc., featured on the cover of the February 17, 2014, issue of Time Magazine. The article, titled "The Quantum Quest for a Revolutionary Computer," introduces readers to the differences between classical and quantum computing and discusses D-Wave's quantum computing technology. The article also discusses D-Wave's early customer traction and the outstanding questions around D-Wave's technology and differentiation. A summary of the article can be viewed at http://content.time.com/time/magazine/article...06,00.html and http://business.time.com/2014/02/06/9-ways-qu...verything/.
10-Q: BEAZER HOMES USA INC
Edgar Online - Fri Jan 31, 4:29PM CST
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Executive Overview and Outlook
Harris & Harris Group Notes Mersana's Second Milestone Payment in Fleximer ADC Collaboration With Endo Pharmaceuticals
GlobeNewswire - Tue Jan 14, 1:44PM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by portfolio company, Mersana Therapeutics, Inc., that it has achieved the second preclinical milestone in its collaboration with Endo Pharmaceuticals. In 2012, Mersana and Endo entered into a multi-target, oncology-focused partnership to develop next-generation Fleximer antibody-drug conjugates (ADCs).
Harris & Harris Group Notes Metabolon's Closing on a $15 Million Series E Financing
GlobeNewswire - Mon Jan 06, 8:30AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the close of Metabolon's $15 million Series E financing. Metabolon is a metabolomics-based diagnostic tests and research services company based in Research Triangle Park, NC. Two new investors, Camden Partners and Sumitomo Corporation, joined existing investors in the Series E financing. Harris & Harris Group invested approximately $1.25 million, bringing its cumulative investment in Metabolon to $7.225 million.
Harris & Harris Group Notes ABSMaterials' Series B Financing
GlobeNewswire - Fri Nov 22, 8:00AM CST
Harris & Harris Group, Inc. (Nasdaq:TINY), an investor in transformative companies enabled by disruptive science, notes the announcement by ABSMaterials, Inc., of its Series B financing. RKS Ventures, a strategic investment group based in Nashua, NH, led the Series B financing round, raising over $4 million. RKS is joined by existing investors, including Harris & Harris Group and a number of individuals. The funding will be used for manufacturing improvements and expansion into new markets, including Asia.
